Log in to search using one of your social media accounts:

 

Artificial intelligence quickly and accurately diagnoses eye diseases and pneumonia
(University of California - San Diego) Using artificial intelligence and machine learning techniques, researchers at Shiley Eye Institute at UC San Diego Health and University of California San Diego School of Medicine, with colleagues in China, Germany and Texas, have developed a new computational tool to screen patients with common but blinding retinal diseases, potentially speeding diagnoses and treatment. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 22, 2018 Category: Infectious Diseases Source Type: news

Retinal images can be used to predict cardiovascular risk
A study inNature Biomedical Engineering reports that using pictures of the retina can be useful to predict cardiovascular risk factors.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 21, 2018 Category: Endocrinology Source Type: news

AMD Treat-and-Extend Regimens OK: Ophthalmology Times
(MedPage Today) -- Also, gene therapy approved for retinal dystrophy (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - February 20, 2018 Category: Primary Care Source Type: news

Google AI now can predict cardiovascular problems from retinal scans
Google AI has made a breakthrough: successfully predicting cardiovascular problems such as heart attacks and strokes simply from images of the retina, with no blood draws or other tests necessary. (Source: mobihealthnews)
Source: mobihealthnews - February 20, 2018 Category: Information Technology Source Type: news

Second Sight Medical enters Singapore market, touts 1st procedure in region
Second Sight Medical (NSDQ:EYES) said today it entered the Singapore market with its Argus II retinal prosthesis system through its regional exclusive distribution partner Mandarin Opto-Medic. The Sylmar, Calif.-based company said that its Argus II systems have been used in their first commercial procedure in the region, implanted last month in a 62-year-old patient with retinal degeneration at the Singapore National Eye Center by Dr. Edmund Wong and Dr. Laurence Lim with supervision from Dr. Emin Özmert. The Argus II induces visual perception in blind patients with retinitis pigmentosa by stimulating of the...
Source: Mass Device - February 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Optical/Ophthalmic Second Sight Source Type: news

Nigeria:Nigerian Student Invents Procedure That Could Revolutionise Retinal Disease Diagnosis
[This Day] A Nigerian doctoral student at Brunel University London's Department of Computer Science, Bashir Dodo, has won the "Best Student Paper" award at the industry-leading BIOIMAGING 2018 conference in Portugal. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 15, 2018 Category: African Health Source Type: news

Phase II Data Support Potential for Novel Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody, RG7716, for People With Diabetic Macular Edema
RG7716 is the first bispecific antibody designed specifically for the treatment of retinal eye diseases RG7716 demonstrated clinically meaningful and statistically significant improvements in visual acuity Key secondary and exploratory anatomical out... Biopharmaceuticals, Ophthalmology Genentech, Roche Group, diabetic macular edema, Anti-VEGF, Anti-Angiopoietin-2 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 14, 2018 Category: Pharmaceuticals Source Type: news

Weekend Recipe: A Healthy Carrot Cake
I designed my healthy carrot cake recipe when I opened The Healthy Chef Café in Avalon Beach in Sydney, Australia. It was a hangout for moms, kids, yogis, supermodels and pro surfers — a place where a variety of people could get nourished and feel great. This cake has over one pound of fresh grated carrot, so it’s packed with goodness and fiber. The large amount of carrots in this recipe also helps to keep the cake moist, which is important due to the longer baking time. When making gluten-free cakes, I find ground almonds make a great replacement for the usual white refined flours that you’ll find...
Source: TIME: Health - February 8, 2018 Category: Consumer Health News Authors: Teresa Cutter — The Healthy Chef Tags: Uncategorized Food healthytime Recipes Teresa Cutter The Healthy Chef Source Type: news

Follow-up Insufficient After Retinal Infarction Follow-up Insufficient After Retinal Infarction
Despite retinal infarction being a harbinger of subsequent stroke, patients with that condition don't receive proper risk factor evaluation and only 8% are referred to a neurologist, a new study shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 7, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Google ‘robomedics’ spot disease faster than doctors
Google ’s London-based AI firm, DeepMind, used retinal scans from thousands of patients to develop an algorithm that spots disease. (Source: the Mail online | Health)
Source: the Mail online | Health - February 6, 2018 Category: Consumer Health News Source Type: news

Second Sight touts 1st-in-human Orion cortical implant
Second Sight Medical (NSDQ:EYES) today announced the first trial implantation of its Orion cortical visual prosthesis system and updated on implantations of its Argus device and enrollment in an upcoming study. The first implantation procedure was performed late last month by Dr. Nader Pouratian at the Ronald Reagan UCLA Medical Center, the Sylmar, Calif.-based company said, as part of an FDA-cleared feasibility trial it won approval to launch last November. The Orion cortical visual prosthesis system is designed to convert images captured by a miniature video camera, mounted on a patient’s glasses, into a ...
Source: Mass Device - February 5, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Optical/Ophthalmic Second Sight Source Type: news

Multimodal retinal imaging in a case of an unsuccessful suicide attempt with sildenafil - Papageorgiou E, Xanthou F, Fili P, Tsironi EE, Androudi S.
[Abstract unavailable] Language: en... (Source: SafetyLit)
Source: SafetyLit - February 5, 2018 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

DeepMind develops AI to diagnose eye diseases
Retinal scans used to train an algorithm in ‘promising’ partnership with the NHS (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - February 4, 2018 Category: Pharmaceuticals Source Type: news

Pixium Vision touts 1st use of Prima bionic vision system
Pixium Vision (EPA:PIX) yesterday announced the first successful trial implantation and activation of its Prima next-generation miniaturized wireless photovoltaic sub-retinal implant, and that the system successfully produced visual perception. With the implantation complete, the patient will begin the re-education phase of the study which includes a six-month and 36-month follow-up, the Paris-based company said. “This first successful activation is a major milestone, validating Prima’s concept in patients with advanced dry AMD. The close collaboration between our team at Stanford University and Pixium Vis...
Source: Mass Device - January 26, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Optical/Ophthalmic Pixium Vision Source Type: news

IRIS Announces Changes and Additions to Its Executive Leadership Team
Imaging Systems Leader Eclipses 250,000 Diabetic Retinopathy Examinations and Positions Itself for Continued Growth PENSACOLA, Fla., Jan. 25, 2018 -- (Healthcare Sales & Marketing Network) -- Intelligent Retinal Imaging Systems (IRIS), the industry lea... Devices, Ophthalmology, Personnel Intelligent Retinal Imaging Systems, diabetic retinopathy, telemedicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 25, 2018 Category: Pharmaceuticals Source Type: news

Topcon ’ s ocular diagnostic instrument lands 510(k) clearance
Topcon Medical Systems said today that its DRI OCT Triton Series system won 510(k) clearance from the FDA. The company’s ocular diagnostic instrument features a built-in retinal camera, eye-tracking and a 1 micron, 1050 nm light source with a scanning speed of 100,000 A-scans/second. Topcon’s touted its system as being able to quickly penetrate ocular tissues without being obscured by hemorrhage or media opacities. It also includes widefield OCT scanning with a reference database. Topcon added that the system displays high-resolution images with clear retinal vessel and macular mapping. “Swept Source OCT ...
Source: Mass Device - January 22, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: 510(k) Food & Drug Administration (FDA) Optical/Ophthalmic Regulatory/Compliance Topcon Source Type: news

Maintaining adequate levels of vitamin D can be a challenge; research suggests eating fortified foods
(Natural News) Combining vitamin D-fortified foods with supplements may help ensure safe and adequate levels of the essential vitamin, a study published in the European Journal of Nutrition revealed. A team of scientists at the Technical University of Denmark pooled data from the Danish National Survey of Dietary Habits and Physical Activity (DANSDA) to carry out the... (Source: NaturalNews.com)
Source: NaturalNews.com - January 21, 2018 Category: Consumer Health News Source Type: news

Spotlight on Retinal Diseases Spotlight on Retinal Diseases
New anti-VEGF therapies for DME and AMD, as well as retinal detachment outcomes, were among the highlights presented at Retina Subspecialty Day during AAO 2017.Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 17, 2018 Category: Consumer Health News Tags: Ophthalmology Commentary Source Type: news

Inner Retinal Abnormalities May Predict DME Outcomes (CME/CE)
(MedPage Today) -- Linked to outer retinal pathology, poorer vision (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - January 12, 2018 Category: Endocrinology Source Type: news

Microvascular Endothelial Cells
Tested, Characterized and Research ReadyOurMicrovascular Endothelial Cells continue to work and work in the hands of our customers.Check out these pubs:1. Odunayo O. Mugisho, Colin R. Green, Jie Zhang, Nicolette Binz, Monica L. Acosta, Elizabeth Rakoczy and Ilva D. Rupentha. (2017).Immunohistochemical Characterization of Connexin43 Expression in a Mouse Model of Diabetic Retinopathy and in Human Donor Retinas. Int. J. Mol. Sci. doi: 10.3390/ijms18122567 2. Michael Anthony Ruiz, Biao Feng, and Subrata Chakrabarti. (2015).Polycomb Repressive Complex 2 Regulates MiR-200b in Retinal Endothelial Cells: Potential Relev...
Source: Neuromics - January 9, 2018 Category: Neuroscience Tags: Diabetic retinopathy endothelial cells human microvascular endotothelial cells Human Retinal Microvascular Endothelial Cells Source Type: news

Pixium Vision wins FDA nod for Prima sub-retinal implant study
Pixium Vision (EPA:PIX) said today it won FDA approval to launch a clinical feasibility trial of its Prima next-gen miniaturized wireless photovoltaic sub-retinal implant designed to treat patients with atrophic dry age-related macular degeneration. The trial of the device, which is slated to be conducted at the University of Pittsburgh Medical Center, aims ot recruit 5 patients with vision loss due to atrophic dry age-related macular degeneration, the Paris-based company said. The study’s primary endpoint will be the restoration of visual perception and safety at 12-months, with a longer-term follow up at ...
Source: Mass Device - January 4, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Food & Drug Administration (FDA) Optical/Ophthalmic Pixium Vision Source Type: news

Gene therapy for rare retinal disorder to cost $425,000 per eye
A one-time treatment with Luxturna, the first US Food and Drug Administration-approved gene therapy for an inherited disorder, will cost $425,000 per eye. (Source: CNN.com - Health)
Source: CNN.com - Health - January 3, 2018 Category: Consumer Health News Source Type: news

Scientists advance stem cell therapy for a leading cause of blindness
Researchers made advances toward creating stem cell-derived retinal cells used to treat a leading cause of blindness. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 2, 2018 Category: Consumer Health News Source Type: news

NIH discovery brings stem cell therapy for eye disease closer to the clinic
Stem cell-derived retinal cells need primary cilia to support survival of light-sensing photoreceptors. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - January 2, 2018 Category: American Health Source Type: news

NIH discovery brings stem cell therapy for eye disease closer to the clinic
(NIH/National Eye Institute) Scientists at the National Eye Institute report that tiny tube-like protrusions called primary cilia on cells of the retinal pigment epithelium (RPE) -- a layer of cells in the back of the eye -- are essential for the survival of the retina's light-sensing photoreceptors. The discovery has advanced efforts to make stem cell-derived RPE for transplantation into patients with geographic atrophy, otherwise known as dry age-related macular degeneration (AMD), a leading cause of blindness in the US. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 2, 2018 Category: Biology Source Type: news

Calcium, Vitamin D Don't Reduce Risk of Bone Fractures
by William E. Gibson, AARP, December 28, 2017|Comments: 0. Calcium and Vitamin D Ineffective Hip Fracture. Getty Images. Researchers found that calcium or vitamin D supplements did not make a significant difference in the risk of hip fractures. Many people take vitamins or find other ways to boost their intake of vitamin  ... (Source: AARP.org News)
Source: AARP.org News - December 29, 2017 Category: American Health Source Type: news

How this biotech plans to go up against big pharma with its eye disease products
Shankar Musunuri has spent time in both the pharmaceutical world and the biotech arena – after 15 years at Pfizer (NYSE:PFE), he went on to launch several biotech start-ups. As co-founder, chairman & chief executive of Ocugen, he is looking to bring eye disease products to the patients that big pharma’s drugs have left out. “There’s so much unmet need when you look into retinal diseases,” Musunuri said. Get the full story at our sister site, Drug Delivery Business News. The post How this biotech plans to go up against big pharma with its eye disease products appeared first o...
Source: Mass Device - December 29, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Biotech Optical/Ophthalmic Pharmaceuticals Research & Development Wall Street Beat Allergan Massachusetts Eye & Ear Infirmary ocugen Pfizer Regeneron Roche Shire Plc. Source Type: news

Iridology proven to have scientific basis? Retinal scan could become early detection system for Alzheimer’s disease
(Natural News) Alzheimer’s disease has been the subject of much research in recent times, as the rate at which this devastating disease affects our growing elderly population skyrockets, but it remains largely mysterious to scientists. For all the studies showing how eating the right foods can help prevent the illness, there are still a lot... (Source: NaturalNews.com)
Source: NaturalNews.com - December 28, 2017 Category: Consumer Health News Source Type: news

New Angiography Technique Improves Imaging in Diabetic Retinopathy New Angiography Technique Improves Imaging in Diabetic Retinopathy
Visualization of the retinal vasculature in patients with diabetic retinopathy is improved with swept-source optical coherence tomography angiography (SS-OCTA) with extended field imaging (EFI), and the technique also affords greater patient comfort than the usual fluorescein angiography (FA), researchers report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 27, 2017 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Vitamin A Deficiency in Chronic Cholestatic Liver Disease Vitamin A Deficiency in Chronic Cholestatic Liver Disease
This review summarizes current knowledge on the role of Vitamin A in disease progression in cholestatic liver disease. Is there a place for retinoids in treating cholestatic disorders?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 27, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Retinal injury following laser pointer exposure - Birtel J, Harmening WM, Krohne TU, Holz FG, Issa PC, Herrmann P.
BACKGROUND: Recent years have seen a marked increase in laser-pointer-related injuries, which sometimes involve severe retinal damage and irreversible visual impairment. These injuries are often caused by untested or incorrectly classified devices that are... (Source: SafetyLit)
Source: SafetyLit - December 25, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

New laser scanners shed light on eye disease before vision loss occurs
(Simon Fraser University) A Simon Fraser University engineering scientist has developed a high resolution retinal imaging scanner that will one day revolutionize eye care, helping ophthalmologists diagnose eye diseases before vision loss occurs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 21, 2017 Category: International Medicine & Public Health Source Type: news

Endoscopes Over Microscopes in Retinal Surgery: Ophthalmology Times
(MedPage Today) -- Also, chandelier illumination may improve outcomes (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - December 20, 2017 Category: Primary Care Source Type: news

FDA approves gene therapy to fix mutations that can lead to blindness
In a decision that accelerates a new era for gene therapy, the Food and Drug Administration on Tuesdayapproved a DNA-altering medication that can reverse an inherited form of progressive blindness.The FDA ’s blessing makes Luxturna, a treatment for retinal dystrophy caused by a specific genetic... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - December 20, 2017 Category: Science Authors: Melissa Healy Source Type: news

Gene Therapy for Inherited Retinal Dystrophy Gets FDA Clearance
(MedPage Today) -- Luxturna is first approved gene therapy to replace a specific mutated gene (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - December 19, 2017 Category: American Health Source Type: news

FDA approves gene therapy for inherited blindness developed by the University of Pennsylvania and Children's Hospital of Philadelphia
(University of Pennsylvania School of Medicine) In a historic move, the US Food and Drug Administration (FDA) today approved a gene therapy initially developed by researchers at the University of Pennsylvania and Children's Hospital of Philadelphia (CHOP) for the treatment of a rare, inherited form of retinal blindness. The decision marks the nation's first gene therapy approved for the treatment of a genetic disease, and the first in which a new, corrective gene is injected directly into a patient. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 19, 2017 Category: International Medicine & Public Health Source Type: news

Effectiveness of vitamin A supplementation for preventing morbidity and mortality in children: What's the Evidence?
February 16, 2018 12:00-1:00pm ET. (Source: HSR Information Central)
Source: HSR Information Central - December 15, 2017 Category: International Medicine & Public Health Source Type: news

Solar Eclipse: High-Resolution Imaging Shows Retinal Damage Solar Eclipse: High-Resolution Imaging Shows Retinal Damage
Young adults may be particularly susceptible to solar retinopathy and need to be educated about the risks of directly viewing the sun without certified, protective eyewear.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 13, 2017 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

A drug to treat retinal diseases with drops instead of injections
(FECYT - Spanish Foundation for Science and Technology) The Spanish firm Sylentis has developed a compound to treat diseases of the retina, such as age-related macular degeneration and diabetic retinopathy, which will be administered by ophthalmic drops instead of intraocular injections. The drug, which has been tested in animals, is a small interfering RNA capable of penetrating the cells of the retina and blocking the formation of new blood vessels. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - December 12, 2017 Category: International Medicine & Public Health Source Type: news

Development of a finite-element eye model to investigate retinal hemorrhages in shaken baby syndrome - Nadarasa J, Deck C, Meyer F, Bourdet N, Raul JS, Willinger R.
Retinal hemorrhages (RH) are among injuries sustained by a large number of shaken baby syndrome victims, but also by a small proportion of road accident victims. In order to have a better understanding of the underlying of RH mechanisms, we aimed to develo... (Source: SafetyLit)
Source: SafetyLit - December 8, 2017 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

Second Sight launches Argus retinal prosthesis in Iran
Second Sight Medical (NSDQ:EYES) said today it launched its Argus II retinal prosthesis system in Iran, facilitated through its exclusive distribution partner Arshia Gostar Darman. The Sylmar, Calif.-based company said that the system has been implanted in two patients in the country, with the procedures performed by Dr. Mohsen Farvadin at the Shiraz Pars Hospital and Khalili Hospital, Shiraz Medical Science University in 44-year old and 33-year old patients with retinitis pigmentosa. The Argus II induces visual perception in blind patients with retinitis pigmentosa by stimulating of the retina’s remaining ...
Source: Mass Device - December 5, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Optical/Ophthalmic Second Sight Source Type: news

New quick, portable test for iron, Vitamin A deficiency could save lives
(Cornell University) Cornell University engineers and nutritionists have created a swift solution for a challenging global health problem: a low-cost, rapid test to detect iron and vitamin A deficiencies at the point of care. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 5, 2017 Category: International Medicine & Public Health Source Type: news

Fish oil component preconditions vision cells to survive future injury or disease
(Louisiana State University Health Sciences Center) A team of LSU Health New Orleans scientists discovered that a component of fish oil not only protects cells critical to vision from potentially lethal initial insults, but also from those that occur in the future. The study showed that the omega-3 fatty acid, DHA, and its derivatives 'precondition' photoreceptor and retinal pigment epithelial (RPE) cells to survive. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 30, 2017 Category: International Medicine & Public Health Source Type: news

Structural insights into ion conduction by channelrhodopsin 2
We present high-resolution structures of ChR2 and the C128T mutant, which has a markedly increased open-state lifetime. The structure reveals two cavities on the intracellular side and two cavities on the extracellular side. They are connected by extended hydrogen-bonding networks involving water molecules and side-chain residues. Central is the retinal Schiff base that controls and synchronizes three gates that separate the cavities. Separate from this network is the DC gate that comprises a water-mediated bond between C128 and D156 and interacts directly with the retinal Schiff base. Comparison with the C128T structure r...
Source: ScienceNOW - November 23, 2017 Category: Science Authors: Volkov, O., Kovalev, K., Polovinkin, V., Borshchevskiy, V., Bamann, C., Astashkin, R., Marin, E., Popov, A., Balandin, T., Willbold, D., Büldt, G., Bamberg, E., Gordeliy, V. Tags: Biochemistry, Online Only r-articles Source Type: news

Dexamethasone Does Not Improve Vision in Persistent Diabetic Macular Edema Dexamethasone Does Not Improve Vision in Persistent Diabetic Macular Edema
Adding dexamethasone to continued ranibizumab treatment reduces retinal thickness but does not improve vision in patients with persistent diabetic macular edema (DME), according to results from a phase 2 randomized trial.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 20, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

How about a peanut butter and kale sandwich? Study shows that peanut butter enhances the vitamin A value of kale
(Natural News) It looks like aside from the classic peanut butter and jelly sandwich, there’s another — and healthier — way to enjoy peanut butter. According to a recent study, adding peanut butter to kale can boost the latter’s vitamin A value. According to researchers from South Korea, U.S., and Zimbabwe, peanut butter can help... (Source: NaturalNews.com)
Source: NaturalNews.com - November 20, 2017 Category: Consumer Health News Source Type: news

Chemical burns of the eye: the role of retinal injury and new therapeutic possibilities - Dohlman CH, Cade F, Regatieri CV, Zhou C, Lei F, Crnej A, Harissi-Dagher M, Robert MC, Papaliodis GN, Chen D, Aquavella JV, Akpek EK, Aldave AJ, Sippel KC, D ʼAmico DJ, Dohlman JG, Fagerholm P, Wang L, Shen LQ, González-Andrades M, Chodosh J, Kenyon KR, Foster CS, Pineda R, Melki S, Colby KA, Ciolino JB, Vavvas DG, Kinoshita S, Dana R, Paschalis EI.
PURPOSE: To propose a new treatment paradigm for chemical burns to the eye - in the acute and chronic phases. METHODS: Recent laboratory and clinical data on the biology and treatment of chemical burns are analyzed. RESULTS: Corneal blindne... (Source: SafetyLit)
Source: SafetyLit - November 17, 2017 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

Stem Cell Therapy Shows Promise for Retinal Degeneration Stem Cell Therapy Shows Promise for Retinal Degeneration
Retinal pigment epithelial cells derived from human embryonic stem cells can be safely transplanted into the eyes of patients with retinal degeneration, with early signs of vision gain.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 17, 2017 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

After cooking, biofortified corn and eggs retain nutrient needed to prevent blindness
(American Chemical Society) Fortified and biofortified foods are at the forefront of efforts to combat vitamin A deficiency worldwide. But little is known about what influence processing may have on the retention of vitamin A precursors in these foods. Now in a study appearing in ACS Omega, scientists report that a high percentage of these healthful substances -- in some cases, almost all -- can survive cooking, depending on the preparation method.   (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 15, 2017 Category: Biology Source Type: news

Genetic treatment for blindness may soon be reality
(American Academy of Ophthalmology) Patients who had lost their sight to an inherited retinal disease could see well enough to navigate a maze after being treated with a new gene therapy, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 10, 2017 Category: International Medicine & Public Health Source Type: news